Panel: How CMOs Balance Science Strategy and Patient Impact Across the Lifecycle

Session details:

• Understand how CMOs prioritize assets and make high-stakes portfolio decisions  
• Identify where Medical Affairs can influence strategy earlier in the lifecycle  
• Learn how leaders balance scientific risk business pressure and patient impact  
• Define what long-term success looks like in a more complex data-driven environment